Guo-Ping Yin
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Natural product bioactivities and synthesis 5
- Plant biochemistry and biosynthesis 5
- RNA modifications and cancer 4
- Pharmacology 14
- Microbial Natural Products and Biosynthesis 14
- Fungal Biology and Applications 8
- Co-authors
- Shizhong Zheng (5 shared papers)Zili Zhang (3 shared papers)Jiangjuan Shao (3 shared papers)Anping Chen (2 shared papers)Min Shen (2 shared papers)Yujia Li (2 shared papers)Yingqian Wang (2 shared papers)Ming‐Hua Yang (6 shared papers)
- Journals
- Fitoterapia (4 papers)Organic Letters (2 papers)Journal of Natural Products (2 papers)Organic Chemistry Frontiers (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Guo-Ping Yin
36 papers receiving 726 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 197
- Cancer Research 164
- Molecular Medicine 53
- Biotechnology 89
- Molecular Biology 399
Countries citing papers authored by Guo-Ping Yin
This map shows the geographic impact of Guo-Ping Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo-Ping Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo-Ping Yin more than expected).
Fields of papers citing papers by Guo-Ping Yin
This network shows the impact of papers produced by Guo-Ping Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo-Ping Yin. The network helps show where Guo-Ping Yin may publish in the future.
Co-authors
The 25 scholars most cited alongside Guo-Ping Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 181 | |
| 2 | 2022 | 73 | |
| 3 | 2018 | 57 | |
| 4 | 2022 | 43 | |
| 5 | 2019 | 36 | |
| 6 | 2020 | 36 | |
| 7 | 2017 | 36 | |
| 8 | 2014 | 35 | |
| 9 | 2017 | 27 | |
| 10 | 2017 | 23 | |
| 11 | 2018 | 23 | |
| 12 | 2020 | 21 | |
| 13 | 2013 | 19 | |
| 14 | 2013 | 17 | |
| 15 | [Advance in chemical constituents and pharmacological activity of Curcuma wenyujin]. | 2012 | 13 |
| 16 | 2013 | 12 | |
| 17 | 2022 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2020 | 7 |
About Guo-Ping Yin
Guo-Ping Yin is a scholar working on Molecular Biology, Pharmacology, Biotechnology, Cancer Research and Food Science, having authored 36 papers that have together received 734 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (14 papers), Fungal Biology and Applications (8 papers), Natural product bioactivities and synthesis (5 papers), Plant biochemistry and biosynthesis (5 papers), RNA modifications and cancer (4 papers), Ziziphus Jujuba Studies and Applications (4 papers), Marine Sponges and Natural Products (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Pharmacology (197 citations), Cancer Research (164 citations), Molecular Medicine (53 citations), Biotechnology (89 citations) and Molecular Biology (399 citations). Guo-Ping Yin has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Shizhong Zheng, Zili Zhang, Jiangjuan Shao, Anping Chen, Min Shen, Yujia Li, Yingqian Wang, Ming‐Hua Yang, Feng Zhang and Jingjing Zhu. Their work appears in journals such as Fitoterapia, Organic Letters, Journal of Natural Products, Organic Chemistry Frontiers and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.